Surface modification and nanodelivery of hypocrellin-based photosensitizers: photophysical optimization and biomedical applications

Photodynamic therapy (PDT) has emerged as an advanced therapeutic modality owing to its inherent merits of minimal invasiveness and precise spatiotemporal control. However, its clinical translation is hampered by limitations of conventional photosensitizers (PSs), including poor aqueous solubility, weak absorption within the 650–800 nm phototherapeutic window (PTW), and inadequate tumor targeting. As a unique natural perylenequinone-based PS endemic to China, hypocrellin exhibits exceptional photophysical properties, such as strong absorption in the visible region and a high singlet oxygen (1O2) quantum yield. Nevertheless, its hydrophobicity and insufficient PTW absorption severely hamper biomedical applications. In recent years, rational modification and nanodelivery engineering have enhanced the aqueous solubility, biocompatibility, and tumor-targeting capability of hypocrellin. Particularly, tailoring surface modifications to redshift absorption to the near-infrared-PTW enables hypocrellin-based nanoplatforms integrated with multimodal synergistic therapies, including PDT, sonodynamic therapy (SDT), chemotherapy, and photothermal therapy (PTT). These nanoplatforms leverage the pathological microenvironment hallmarks to amplify efficacy via synergistic effects. This review summarizes the photodynamic mechanism of hypocrellin, surface modification strategies, and nanodelivery design. Special emphasis is placed on recent advances in spectral regulation and solubility enhancement, along with its applications in antitumor, antibacterial, antiviral, anti-inflammatory, and multimodal therapies. Furthermore, we provide an in-depth analysis of strategies to circumvent tumor hypoxic microenvironment and biosafety challenges of hypocrellin-based nanocarriers. Finally, the development of stimuli-responsive delivery systems is prospected, aiming to provide critical insights for clinical translation of this natural PS.

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-05-18
DOI
https://doi.org/10.1186/s12951-026-04506-y
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Surface modification and nanodelivery of hypocrellin-based photosensitizers: photophysical optimization and biomedical applications

X Y Wang, Xinyu Yu, Hua Jiao, Zhihui Zhao et al.
Journal of Nanobiotechnology
Nanoplatforms for cancer theranostics
article

Surface modification and nanodelivery of hypocrellin-based photosensitizers: photophysical optimization and biomedical applications

X Y Wang, Xinyu Yu, Hua Jiao, Zhihui Zhao, Y Huang, Xiao He, Wenyan Yin
article en

Abstract

Photodynamic therapy (PDT) has emerged as an advanced therapeutic modality owing to its inherent merits of minimal invasiveness and precise spatiotemporal control. However, its clinical translation is hampered by limitations of conventional photosensitizers (PSs), including poor aqueous solubility, weak absorption within the 650–800 nm phototherapeutic window (PTW), and inadequate tumor targeting. As a unique natural perylenequinone-based PS endemic to China, hypocrellin exhibits exceptional photophysical properties, such as strong absorption in the visible region and a high singlet oxygen (1O2) quantum yield. Nevertheless, its hydrophobicity and insufficient PTW absorption severely hamper biomedical applications. In recent years, rational modification and nanodelivery engineering have enhanced the aqueous solubility, biocompatibility, and tumor-targeting capability of hypocrellin. Particularly, tailoring surface modifications to redshift absorption to the near-infrared-PTW enables hypocrellin-based nanoplatforms integrated with multimodal synergistic therapies, including PDT, sonodynamic therapy (SDT), chemotherapy, and photothermal therapy (PTT). These nanoplatforms leverage the pathological microenvironment hallmarks to amplify efficacy via synergistic effects. This review summarizes the photodynamic mechanism of hypocrellin, surface modification strategies, and nanodelivery design. Special emphasis is placed on recent advances in spectral regulation and solubility enhancement, along with its applications in antitumor, antibacterial, antiviral, anti-inflammatory, and multimodal therapies. Furthermore, we provide an in-depth analysis of strategies to circumvent tumor hypoxic microenvironment and biosafety challenges of hypocrellin-based nanocarriers. Finally, the development of stimuli-responsive delivery systems is prospected, aiming to provide critical insights for clinical translation of this natural PS.

Journal of Nanobiotechnology
Xi’an University (CN), National Center for Nanoscience and Technology (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 9%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.